Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Some companies are aligning strictly with FDA-approved uses, while others exclude weight management entirely or impose strict eligibility rules
The Noom Proactive Health GLP-1 Program is priced at $149 per month
For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease ( ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)
use within 12 weeks
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
